Cargando…
Ligand-protein interactions of plant-isolated (9z,12z)-octadeca-9,12-dienoic acid with Β-ketoacyl-Acp synthase (KasA) in potential anti-tubercular drug designing
Mycobacterium tuberculosis remains one of the world's contributors to mortality. With the emergence of SARS-CoV-2 coinfections, patients with TB are predisposed to being more heavily weighed down by COVID-19 disease and its opportunistic coinfections. The severity of the disease coupled with dr...
Autores principales: | Mtewa, Andrew G., Bvunzawabaya, Jonathan T., Ngwira, Kennedy J., Lampiao, Fanuel, Maghembe, Reuben, Okella, Hedmon, weisheit, Anke, Tolo, Casim U., Ogwang, Patrick E., Sesaazi, Duncan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190923/ https://www.ncbi.nlm.nih.gov/pubmed/37215382 http://dx.doi.org/10.1016/j.sciaf.2021.e00824 |
Ejemplares similares
-
SARS-CoV-2 vaccine development
por: Mtewa, Andrew G., et al.
Publicado: (2022) -
Identification of KasA as the cellular target of an anti-tubercular scaffold
por: Abrahams, Katherine A., et al.
Publicado: (2016) -
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA
por: Kumar, Pradeep, et al.
Publicado: (2018) -
Computational Approaches to Identify Molecules Binding
to Mycobacterium tuberculosis KasA
por: Puhl, Ana C., et al.
Publicado: (2020) -
Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design
por: Rudraraju, Reshma S., et al.
Publicado: (2022)